The DOI matches its Crossref record; 33 of the 35 references it cites were found in a registry or an index.
Incidence of Atrial Fibrillation and Relationship With Cardiovascular Events, Heart Failure, and Mortality
Open accessAbstract
Background Important improvements have been made in treatment of diseases associated with atrial fibrillation (AF), such as hypertension, myocardial infarction, and heart failure. Incidence rates and risk factors may have changed with the aging of the population and changing lifestyles. Currently, the risk for AF is only partially explained, possibly because of differences between older cohorts and contemporary populations.Objectives This study investigated the incidence of AF in a contemporary cohort in the Netherlands, together with comorbidities associated with AF and associations of AF with cardiovascular outcomes.Methods Incident AF was ascertained for hospital and study electrocardiograms in 8,265 participants of the PREVEND (Prevention of Renal and Vascular End-Stage Disease) study in Groningen, the Netherlands.Results During 9.7 ± 2.3 years of follow-up, 265 participants developed AF, with a resulting overall AF incidence of 3.3 per 1,000 person-years. Advancing age, male sex, antihypertensive drug use, higher body mass index, previous myocardial infarction, and previous stroke were associated with AF. After multivariable adjustment, AF was associated with cardiovascular events (hazard ratio [HR]: 2.24; 95% confidence interval [CI]: 1.06 to 4.75; p = 0.035), heart failure with either reduced or preserved ejection fraction (HR: 4.52; 95% CI: 2.02 to 10.09; p < 0.001), and all-cause mortality (HR: 3.02; 95% CI: 1.73 to 5.27; p < 0.001).Conclusions The incidence of AF in the present cohort was comparable to that shown in data of older studies. Obesity has become a major risk factor for incident AF. Although overall cardiovascular event rates were lower in the present study, the present study confirms the association of incident AF with such events.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Obesity 19, 208 none (BMI < 25 kg/m²) overweight (BMI 25-30 kg/m²) obese (BMI ≥ 31 kg/m²) HR: 1.00 (reference) 1.13 (95% CI 0.87-1.46)1.37 (95% CI 1.05-1.78)”
From 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS (2016) · cites this paper as [208]
Citations
Cites
Dabigatran versus warfarin in patients with atrial fibrillation
Connolly, S. J., Ezekowitz, M. D., Yusuf, S., Eikelboom, J., Oldgren, J., Parekh, A., Pogue, J., Reilly, P. A., Themeles, E., Varrone, J., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0905561 · Cited by 11,215
Rivaroxaban versus warfarin in nonvalvular atrial fibrillation
Patel, M. R., Mahaffey, K. W., Garg, J., Pan, G., Singer, D. E., Hacke, W., Breithardt, G., Halperin, J. L., Hankey, G. J., Piccini, J. P., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1009638 · Cited by 9,430
Apixaban versus warfarin in patients with atrial fibrillation
Granger, C. B., Alexander, J. H., McMurray, J. J. V., Lopes, R. D., Hylek, E. M., Hanna, M., Al-Khalidi, H. R., Ansell, J., Atar, D., Avezum, A., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1107039 · Cited by 8,943
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
January, C. T., Wann, L. S., Alpert, J. S., Calkins, H. G., Cigarroa, J. E., Cleveland, J. C., CONTI, J. B., Ellinor, P. T., Ezekowitz, M. D., Field, M. E., et al. (2014) · Circulation · doi:10.1161/cir.0000000000000041 · Cited by 7,145
Guidelines for the management of atrial fibrillation
Authors/Task Force Members, Camm, A. J., Kirchhof, P. F., Lip, G. Y. H., Schotten, U., Savelieva, I., Ernst, S., Gelder, I. C. V., Al‐Attar, N., Hindricks, G., et al. (2010) · European Heart Journal · doi:10.1093/eurheartj/ehq278 · Cited by 5,924
Impact of Atrial Fibrillation on the Risk of Death: The Framingham Heart Study
Benjamin, E. J., Wolf, P. A., D’Agostino, R. B., Silbershatz, H., Kannel, W. B., & Levy, D. (1998) · Circulation · doi:10.1161/01.cir.98.10.946 · Cited by 4,575
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
January, C. T., Wann, L. S., Alpert, J. S., Calkins, H., Cigarroa, J. E., Cleveland, J. C., Conti, J. B., Ellinor, P. T., Ezekowitz, M. D., Field, M. E., et al. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2014.03.022 · Cited by 2,955
Benjamin, E. J. (1994) · JAMA · doi:10.1001/jama.1994.03510350050036 · Cited by 2,613
Miyasaka, Y., Barnes, M. E., Gersh, B. J., Cha, S. S., Bailey, K. R., Abhayaratna, W. P., Seward, J. B., & Tsang, T. S. M. (2006) · Circulation · doi:10.1161/circulationaha.105.595140 · Cited by 2,564
Subclinical atrial fibrillation and the risk of stroke
Healey, J. S., Connolly, S. J., Gold, M. R., Israel, C. W., Van Gelder, I. C., Capucci, A., Lau, C. P., Fain, E., Yang, S., Bailleul, C., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1105575 · Cited by 2,100
Flagged first, then by citations
2 of the 35 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Items 201–297 of 297
Tarniceriu, A., Vuohelainen, V., Haddad, S., Halkola, T., Parák, J., Laurikka, J. O., & Vehkaoja, A. T. (2019) · Tampere University Institutional Repository (Tampere University) · doi:10.23919/cinc49843.2019.9005734 · Cited by 4
Boersma, L. V. A., Rienstra, M., & de Groot, J. R. (2020) · Netherlands Heart Journal · doi:10.1007/s12471-020-01447-5 · Cited by 4
Lyu, S., Yang, Y., Zhu, J., Wang, J., Wu, S., Ren, J., Zhang, H., & Shao, X. (2020) · Europe PMC (PubMed Central) · doi:10.11909/j.issn.1671-5411.2020.12.005 · Cited by 5
Xia, S., Du, X., Li, C., Wu, J., Tang, R., Chang, S., Guo, X., Yu, R., Long, D., Bai, R., et al. (2016) · International Journal of Cardiology · doi:10.1016/j.ijcard.2016.06.113 · Cited by 4
Dapagliflozin effect on heart failure with prevalent or new‐onset atrial fibrillation
Arita, V. A., van Veldhuisen, D. J., & Rienstra, M. (2022) · European Journal of Heart Failure · doi:10.1002/ejhf.2443 · Cited by 4
Pulmonary Vein Morphology in Patients Undergoing Catheter Ablation of Atrial Fibrillation
Barbora, F., Toman, O., Pospíšil, D., Monika, M., Nela, H., Anna, Z. P., Křikavová, L., Martin, F., Sepši, M., Petr, K. J., et al. (2024) · Cardiovascular Engineering and Technology · doi:10.1007/s13239-024-00738-x · Cited by 3
Esposito, R., Menna, P., Salvatorelli, E., Camilli, M., & Minotti, G. (2025) · European Cardiology Review · doi:10.15420/ecr.2025.32 · Cited by 3
Himmelreich, J. C. L., Harskamp, R. E., Geelhoed, B., Virdone, S., Lucassen, W. A. M., Gansevoort, R. T., & Rienstra, M. (2022) · BMJ Open · doi:10.1136/bmjopen-2021-057476 · Cited by 3
How sex affects the sinus rhythm heartbeat
Veen, D., Schram‐Serban, C., van Schie, M. S., van Schaagen, F. R. N., Knops, P., Kavousi, M., Taverne, Y. J. H. J., & de Groot, N. M. S. (2023) · IJC Heart & Vasculature · doi:10.1016/j.ijcha.2023.101314 · Cited by 3
“Atrial fibrillation (AF) for example, occurs more frequently in males than in females, irrespective of age [1,2].”
BackgroundAbbas, H., Younis, A., Goldenberg, I., McNitt, S. A., Aktaş, M. K., Tabaja, C., & Ojo, A. O. (2024) · Journal of Cardiovascular Electrophysiology · doi:10.1111/jce.16280 · Cited by 3
“22,23 4 We also demonstrate an increased risk of death among patients with VT/VF despite having an ICD in place.”
BackgroundAssociations of Depression, Antidepressants with Atrial Fibrillation Risk in HFpEF Patients
Fu, Y., Feng, S., Gu, Z., Liu, X., Zhu, W., Wei, B., & Guo, L. (2024) · Reviews in Cardiovascular Medicine · doi:10.31083/j.rcm2510370 · Cited by 3
Nasir, A., Farooqi, A. T., Sattar, S., & Saeed, Y. (2025) · Heart Rhythm O2 · doi:10.1016/j.hroo.2024.12.017 · Cited by 3
Development and Validation of a Risk Score in Chinese Patients With Chronic Heart Failure
Lin, M., Zhan, J., Luan, Y., Li, D., Shan, Y., Xu, T., Fu, G., Zhang, W., & Wang, M. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.865843 · Cited by 3
Ding, W. Y., Davies, I. G., Gupta, D., & Lip, G. Y. H. (2022) · Biomedicines · doi:10.3390/biomedicines10092270 · Cited by 3
Bonnesen, K., Heide‐Jørgensen, U., Sørensen, H. T., & Schmidt, M. (2023) · Journal of Stroke and Cerebrovascular Diseases · doi:10.1016/j.jstrokecerebrovasdis.2023.107219 · Cited by 3
Heart failure with preserved ejection fraction and atrial fibrillation
Lenormand, T., Bisson, A., & Fauchier, L. (2025) · Minerva Medica · doi:10.23736/s0026-4806.25.09602-8 · Cited by 3
Siland, J. E., Zwartkruis, V. W., Geelhoed, B., de Boer, R. A., Gelder, I. C. V., van der Harst, P., & Rienstra, M. (2020) · IJC Heart & Vasculature · doi:10.1016/j.ijcha.2020.100492 · Cited by 3
“Many of the traditional risk factors of incident atrial fibrillation (AF) as advanced age,male sex, hypertension, diabetesmellitus,myocardial infarction, heart failure, valvular heart disease, and obesity are related to lifestyle [2].”
BackgroundSiland, J. E., Nguyen, B., With, R. R. D., Gelder, I. C. V., van der Harst, P., & Rienstra, M. (2021) · PLoS ONE · doi:10.1371/journal.pone.0246907 · Cited by 3
“Genetically-determined BMI and observed BMI in the GGAF population Observed BMI� 30 kg/m(2) increases the risk by approximately 50% for developing AF [15].”
BackgroundKomatsu, J., Imai, R., Nakaoka, Y., Nishida, K., Seki, S.-I., Kubo, T., Yamasaki, N., Kitaoka, H., Kubokawa, S., Kawai, K., et al. (2021) · Circulation Reports · doi:10.1253/circrep.cr-20-0101 · Cited by 3
Atrial fibrillation: Can it be as easy as CC to ABC?
Ding, W. Y., Lip, G. Y. H., & Potpara, T. (2020) · European Journal of Clinical Investigation · doi:10.1111/eci.13413 · Cited by 3
How Sex Affects the Sinus Rhythm HeartbeatPreprint
de Groot, N. M. S., Veen, D., Schram‐Serban, C., van Schie, M. S., van Schaagen, F. R. N., Knops, P., Kavousi, M., & Taverne, Y. J. H. J. (2023) · doi:10.22541/au.169289660.03247555/v1 · Cited by 3
Zou, Y., Wang, P., Du, L., Chen, X., Li, Z., Song, J., & Fang, Z. (2025) · Bioengineering · doi:10.3390/bioengineering12010044 · Cited by 4
“Atrial fibrillation can significantly increase the risk of developing other high-risk cardiovascular diseases, including stroke [3], systemic embolism [4], vascular dementia [4], heart failure [5], myocardial infarction [6], and sudden cardiac death [7].”
Li, C., He, D., Liu, Y., Yang, C., Zhang, L., & Pop‐Busui, R. (2025) · The Journal of Prevention of Alzheimer s Disease · doi:10.1016/j.tjpad.2024.100047 · Cited by 2
Egami, Y., Kobayashi, N., Sugino, A., Abe, M., Ohsuga, M., Nohara, H., Kawanami, S., Ukita, K., Kawamura, A., Yasumoto, K., et al. (2025) · Journal of Cardiology · doi:10.1016/j.jjcc.2025.05.003 · Cited by 2
Long-term prognosis in early-onset atrial fibrillation without overt cardiovascular disease
Holt, A., Strange, J. E., Gislason, G., Schou, M., Lamberts, M., Hansen, M. L., & Rasmussen, P. V. (2025) · Heart Rhythm · doi:10.1016/j.hrthm.2025.09.044 · Cited by 4
Jan, Z., Hudzik, B., Jolanta, N., & Gąsior, M. (2025) · Current Problems in Cardiology · doi:10.1016/j.cpcardiol.2025.103231 · Cited by 2
Ahn, H., Paeng, J. C., Kim, K., Park, C. S., Lee, S., Choi, E., & Oh, S. (2026) · Korean Circulation Journal · doi:10.4070/kcj.2025.0292 · Cited by 2
“3) This has raised important questions about the underlying mechanisms contributing to AF in different age groups.”
Kok, T. F., van Essen, B. J., Weerts, J., Yang, Y., Achten, A., Gansevoort, R. T., Bakker, S. J. L., van Empel, V. P. M., Damman, K., Boersma, E. H., et al. (2026) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2025.08.022 · Cited by 2
Folomeeva, L. I., & Филиппов, Е. В. (2020) · Rational Pharmacotherapy in Cardiology · doi:10.20996/1819-6446-2020-2020-08-17 · Cited by 2
Coronary Lesions in Patients with Atrial Fibrillation: A Retrospective Study
Chen, Y., & Xia, S.-D. (2021) · Exploratory Research and Hypothesis in Medicine · doi:10.14218/erhm.2020.00077 · Cited by 2
Characteristics of Associated Diseases in Older Patients with Cardiovascular Disease
Alyami, S. S., Algharbi, A. M. A., & Alsuwaidan, S. D. (2022) · Advances in Aging Research · doi:10.4236/aar.2022.116011 · Cited by 3
Daytime Napping, Incident Atrial Fibrillation, and Dynamic Transitions With Dementia
Li, C., He, D., Yang, C., & Zhang, L. (2024) · JACC Advances · doi:10.1016/j.jacadv.2024.101108 · Cited by 2
Cao, L., Guo, X., Liao, K., Qin, J., & Zheng, Y. (2024) · Clinical Cardiology · doi:10.1002/clc.70022 · Cited by 2
“Vermond et al. [33] have found that both HFpEF and atrial fibrillation are linked not only with advanced age, hypertension, and diastolic dysfunction but also with adverse cardiovascular outcomes.”
BackgroundRate Versus Rhythm Control for Atrial Fibrillation with Heart Failure
Saksena, S. V., & Slee, A. E. (2024) · Cardiac Electrophysiology Clinics · doi:10.1016/j.ccep.2024.09.002 · Cited by 2
Kumar, N. (2025) · Premier Journal of Cardiology · doi:10.70389/pjc.100009 · Cited by 2
Lien, C.-H., Hsu, K.-C., Chang, Y.-K., CHANG, C., Chiu, Y., & Hsu, H.-Y. (2025) · Heart Rhythm · doi:10.1016/j.hrthm.2025.03.2001 · Cited by 2
Egami, Y., Kobayashi, N., Sugino, A., Abe, M., Osuga, M., Nohara, H., Kawanami, S., Ukita, K., Kawamura, A., Yasumoto, K., et al. (2025) · Heart Rhythm · doi:10.1016/j.hrthm.2025.02.021 · Cited by 2
Suthahar, N., Gansevoort, R. T., Kok, T. F., El‐Qendouci, M., Petersen, T. B., Bakker, S. J. L., Boersma, E. H., Damman, K., Kardys, I., Rienstra, M., et al. (2025) · npj Cardiovascular Health · doi:10.1038/s44325-025-00079-1 · Cited by 2
Lee, S.-R., Lee, Y.-S., Lim, W., Kim, T.-H., Cha, M., Lee, J., Baek, Y., Lim, H., Joung, B., Kim, J., et al. (2018) · Korean Journal of Medicine · doi:10.3904/kjm.2018.93.4.324 · Cited by 2
Dye, C. A., Skeete, J., Khan, A., Dunleavy, M., Dietrich, M., Volgman, A. S., Sharma, P. S., & Huang, H. D. (2023) · Pharmacoepidemiology · doi:10.3390/pharma2010008 · Cited by 2
“Moreover, patients with CHF are 4.5 to 6 times more likely to develop AF than patients without CHF [26].”
BackgroundInfluentialProgression of Device-Detected Atrial High-Rate Episodes and the Risk of All-Cause Mortality
Jiang, J., Sun, X., Cheng, C., Chen, K., Hua, W., Su, Y., Xu, W., Chen, R., & Zhang, S. (2023) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2023.07.013 · Cited by 2
Knoka, E., Pupkeviča, I., Luriņa, B., Kamzola, G., Strēlnieks, A., Kalējs, O., & Lejnieks, A. (2017) · Cor et Vasa · doi:10.1016/j.crvasa.2017.08.005 · Cited by 2
Taniguchi, N., Miyasaka, Y., Suwa, Y., Harada, S., Nakai, E., & Shiojima, I. (2023) · Heart and Vessels · doi:10.1007/s00380-023-02252-x · Cited by 1
Shropshire, S. J., Manemann, S. M., Jiang, R., Vaughan, L. E., Noseworthy, P. A., Siontis, K. C., Attia, Z. I., Gersh, B. J., & Chamberlain, A. M. (2026) · Mayo Clinic Proceedings Digital Health · doi:10.1016/j.mcpdig.2026.100347 · Cited by 1
Hirose, K., Nakanishi, K., Daimon, M., Iwama, K., Yoshida, Y., Mukai, Y., Yamamoto, Y., Seki, H., Hirokawa, M., Nakao, T., et al. (2026) · Journal of the American Heart Association · doi:10.1161/jaha.125.045579 · Cited by 1
Subclinical atrial fibrillation and the risk of heart failure: insights from ARTESiA
Frausing, M. H. J. P., McIntyre, W. F., Healey, J. S., Kovalova, T., Wong, J. A., Diederichsen, S. Z., Xing, L. Y., Granger, C. B., Lópes, R. D., Benz, A. P., et al. (2026) · European Journal of Heart Failure · doi:10.1093/ejhf/xuag022 · Cited by 1
Che, Q.-J., Zhang, Y.-C., Chen, M., Yao, P., Wang, Q., Sun, J., Li, W., Liu, B., Zhang, P., Yu, Y.-C., et al. (2026) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2026.1871243 · Cited by 1
Aging and Heart Failure With Preserved Ejection Fraction
MacNamara, J. P., Sarma, S., & Levine, B. D. (2020) · Elsevier eBooks · doi:10.1016/b978-0-323-64067-1.00031-0 · Cited by 1
Lakkireddy, D. (2020) · Journal of Atrial Fibrillation · doi:10.4022/jafib.20200468 · Cited by 1
Zakharov, I. P., Borenstein, A. I., Kuznetsova, N., Парисович, С. В., Kopylov, P., Andreev, D. A., & Chomakhidze, P. S. (2023) · Russian Journal of Cardiology and Cardiovascular Surgery · doi:10.17116/kardio20231601156 · Cited by 1
Zakharov, I. P., Chomakhidze, P. S., Kopylov, F. Y., Sultygova, E. A., Фератовна, М. Д., Lyubimova, E. A., & Andreev, D. A. (2024) · Kardiologiia · doi:10.18087/cardio.2024.3.n2466 · Cited by 1
Egami, Y., Kobayashi, N., Sugino, A., Abe, M., Osuga, M., Nohara, H., Kawanami, S., Ukita, K., Kawamura, A., Yasumoto, K., et al. (2024) · Journal of Cardiovascular Electrophysiology · doi:10.1111/jce.16464 · Cited by 1
Kiefer, N., Oremek, M. J. G., Hoeft, A., & Zenker, S. (2019) · Computational and Mathematical Methods in Medicine · doi:10.1155/2019/9682138 · Cited by 1
“HF: Heart failure AF: Atrial fibrillation LVDD: Left ventricular dysfunction HFpEF: Heart failure with preserved ejection fraction LVDF: Left ventricular diastolic function EDV: End-diastolic volume ABP: Invasive arterial blood pressure SR: Sinus rhythm RRI: RR intervals PP: Pulse pressure SM: Simple model EM: Expande…”
BackgroundInfluentialPermanent atrial fibrillation in patients with a dual‑chamber pacemaker
Dębski, M., Ulman, M., Ząbek, A., Boczar, K., Haberka, K., Kuniewicz, M., Lelakowski, J., & Małecka, B. (2019) · Kardiologia Polska · doi:10.33963/kp.14974 · Cited by 1
Antihypertensive Drug Usage in Prediction of Incident Atrial Fibrillation
Onat, A., Şimşek, B., & Akbaş, T. (2016) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2015.11.072 · Cited by 1
Atrial fibrillation in adult congenital heart disease in AsiaPreprint
Chiu, S.-N., Tseng, W.-C., Lu, C.-W., Lin, M.-T., Chen, C., Wang, J.-K., & Wu, M.-H. (2023) · medRxiv · doi:10.1101/2023.04.20.23288895
Kowey, P. R., & Robinson, V. M. (2015) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2015.07.013
“(3) and are not commonly reported in the literature.”
BackgroundInfluentialKotecha, D. (2016) · International Journal of Cardiology · doi:10.1016/j.ijcard.2016.03.107
“already been made clear from numerous published reports (3-8).”
Vermond, R. A., Geelhoed, B., & Rienstra, M. (2016) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2016.01.048
Risk factors for atrial fibrillation incidence and progression
Vermond, R. A. (2016) · University of Groningen research database (University of Groningen / Centre for Information Technology)
Черняєва, К. І., Rudenko, Y., Mostbauer, G., Bezrodnyi, A., Shevchuk, M., Саблін, А. В., Moskalenko, Y., & Ковтун, Е. Г. (2019) · Ukrainian Scientific Medical Youth Journal · doi:10.32345/usmyj.4(112).2019.32-46
The Research Progress of Cardiac Implantable Electronic Device-Identified Atrial Fibrillation
卢, 江. (2020) · Advances in Clinical Medicine · doi:10.12677/acm.2020.103036
Épidémiologie et mécanismes de la fibrillation atriale
Lacroix, D., & Klein, C. (2020) · Bulletin de l Académie Nationale de Médecine · doi:10.1016/j.banm.2020.07.049 · Cited by 1
ATRIAL FIBRILLATION AND ADHERENCE TO ORAL ANTICOAGULATION: REVIEW OF CLINICAL CASES
Dzeshka, M. S., Бойко, С. Л., Шпак, Н. В., & Snezhitskiy, V. А. (2020) · Emergency Cardiology and Cardiovascular Risks · doi:10.51922/2616-633x.2020.4.2.1019
Steinberg, B. S., Aydin, M. A., Moser, A., Ojeda, F., & Karakas, M. (2021) · Medicina · doi:10.3390/medicina57080776
“Affected patients have an increased risk for thromboembolic events and the development of heart failure, and catheter ablation has now emerged as key interventional therapy and is recommended for drug-refractory AF, although recurrences of AF are common [5].”
BackgroundDilemas de la insuficiencia cardíaca con fracción de eyección preservada
(2021) · Revista Uruguaya de Cardiología · doi:10.29277/cardio.37.1.17
大門, 雅. (2023) · JAPANES JOURNAL OF MEDICAL INSTRUMENTATION · doi:10.4286/jjmi.93.102
Association of Oxidative Stress-related Biomarkers and Atrial Fibrillation: A Cross- Sectional StudyPreprint
Wang, X., Zhang, Y., Ren, M., Guo, J., Li, Z., Zheng, S., Wang, X., Du, J., Gao, M., & Hou, Y. (2023) · Research Square · doi:10.21203/rs.3.rs-3063179/v1
Lu, H., Gao, Z., Wei, H., Wei, Y., Qiu, Z., Xiao, J., & Huang, W. (2023) · medRxiv · doi:10.1101/2023.08.21.23294384
Atrial Fibrillation and Hypertension: Complications and Comorbidities
Čusto, E. B., Ćemalović, S., Bajrić, S., & Cemalovic, N. (2023) · Cardiologia Croatica · doi:10.15836/ccar2024.65
Shastri, M. H., Vinod, V., Mistry, H. P., Rathod, V. M., Gohil, N. V., Dobariya, R. K., & Patel, N. S. (2023) · APIK Journal of Internal Medicine · doi:10.4103/ajim.ajim_50_23
Zhang, B., Han, J., Zhou, D., Jiang, J., Zhong, J., Lu, Y., Zuo, C., Lu, X., Xuan, J., Zu, A., et al. (2024) · PubMed Central · doi:10.57264/cer-2023-0035
Ping, Y., Guoqiang, W., Tiantian, A., Mingbao, S., Yu, X.-J., & Xiaoying, L. (2024) · Research Square · doi:10.21203/rs.3.rs-3935654/v1
Can, C. (2024) · Comprehensive Medicine · doi:10.14744/cm.2024.62207
“[5] The treatment of AF consists of three main components: rate control, rhythm control, and anticoagulation.”
BackgroundOjo, A. O., & Goldenberg, I. (2024) · Journal of Cardiovascular Electrophysiology · doi:10.1111/jce.16306
Atrial Fibrillation in Heart Failure: Strategies for Restoring Sinus Rhythm
Atreya, A. R., Arora, S., Subramanian, M., Yalagudri, S. D., Narasimhan, C., & Saggu, D. K. (2024) · Indian Journal of Clinical Cardiology · doi:10.1177/26324636241261456
Dąbrowska, M., Rząd, M., Kanecki, K., Lewtak, K., Tyszko, P. Z., Goryński, P., & Nitsch-Osuch, A. S. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13216592
“Increasing age is the most important risk factor for atrial fibrillation [3].”
BackgroundInfluentialZhang, L., Xie, Y., Hu, X., Ma, D., & Huang, Y. (2024) · Research Square · doi:10.21203/rs.3.rs-5360355/v1
Mohammadi, R., Rostamzadeh, A., Khademvatani, K., & Yekta, Z. (2024) · Health Science Monitor · doi:10.61186/hsm.3.4.348
Yan, Y., Liu, Q., Wang, Z., Wang, H., & Chang, P. (2025) · Journal of the American Heart Association · doi:10.1161/jaha.125.040958
Hasan, M., Chola, M. H., Ali, T., Azeem, B., Chola, M. S., Naveed, M. A., Ali, A., Soni, K., Jain, H., Chigurupati, H. D., et al. (2025) · Cardiology in Review · doi:10.1097/crd.0000000000001058
Multimorbidity and risk of atrial fibrillation in the Lifelines cohort
van Deutekom, C., Weil, L. I., Middeldorp, M. E., Samuel, M., Geelhoed, B., Velt, M. J. H., Zwartkruis, V. W., Hanssen, D. J. C., Munster, B. C. V., Voshaar, R. C. O., et al. (2025) · European Heart Journal Open · doi:10.1093/ehjopen/oeaf164
“9,30 Few other studies investigated the association between clusters and the risk of incident AF using latent class analysis.”
Kim, B. S., Kwon, C. H., Chang, H., Choi, J.-H., Kim, H.-J., & Kim, S. H. (2023) · Figshare · doi:10.6084/m9.figshare.23167645
Eerdekens, R., Kats, S., Grutters, J. P. C., Green, M., Shore, J., Candolfi, P., Oortwijn, W., van der Harst, P., & Tonino, P. A. L. (2024) · Figshare · doi:10.6084/m9.figshare.25478838
Harnessing Machine Learning for Predicting Atrial Fibrillation from Electrocardiogram Signals
Parale, G. P., Parale, H., Parale, C., & Kumar, S. (2025) · Journal of the Practice of Cardiovascular Sciences · doi:10.4103/jpcs.jpcs_35_25
Chen, J., Chen, S.-F., Li, M., Zhang, L.-M., Li, X., Yan, L.-J., Hu, J., Sun, F., Hu, G.-L., Huang, L.-L., et al. (2026) · Medicine · doi:10.1097/md.0000000000047183
“[12] However, the effects of catheter ablation on the prognosis of young patients aged ≤35 years with AF are not well understood.”
Xie, Y. F., Hu, X., Ma, D., Zhang, L., & Huang, Y. (2026) · Journal of Clinical Medicine · doi:10.3390/jcm15062409
“Catheter-based point-by-point radiofrequency ablation (RFA) is the most widely used technique and has proven to have a high success of AF-free rate [3,4].”
Egami, Y., Mukai, T., Kise, M., Kobayashi, N., Sugino, A., Abe, M., Nohara, H., Kawanami, S., Yasumoto, K., Okamoto, N., et al. (2026) · Pacing and Clinical Electrophysiology · doi:10.1111/pace.70300
Lu, B., Sun, Y., He, L., Sun, S., Wu, J., Chen, B., Fan, H., & Zhao, Z. (2026) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2026.1757839
Exercise for Atrial Fibrillation: Unmasking Comorbidities and Improving Treatment
Dziano, J. K., Ariyaratnam, J., Middeldorp, M. E., Sanders, P., & Elliott, A. D. (2026) · Exercise and Sport Sciences Reviews · doi:10.1249/jes.0000000000000391
Bruton tyrosine kinase inhibitors and cardiovascular adverse events
Camilli, M., Madaudo, C., Salvatorelli, E., Minotti, G., & Menna, P. (2026) · British Journal of Pharmacology · doi:10.1111/bph.70620
Mineralocorticoid receptor overactivation in heart failure with preserved ejection fraction
Kobayashi, M., Pitt, B., & Zannad, F. M. (2026) · European Heart Journal · doi:10.1093/eurheartj/ehag578
Konoma, S., Nakanishi, K., Daimon, M., Hirose, K., Iwama, K., Mukai, Y., Yamamoto, Y., Kobayashi, S., Seki, H., Yoshida, Y., et al. (2026) · Journal of the American Society of Echocardiography · doi:10.1016/j.echo.2026.08.013
The Role of the Pace-And-Ablate Strategy in the Modern Management of Refractory Atrial Fibrillation
Gupta, A. R., DeSimone, C. V., & Siontis, K. C. (2026) · Current Cardiovascular Risk Reports · doi:10.1007/s12170-026-00791-2
“The elevated risk of HF in patients with AF is true for both HFrEF and HFpEF, respectively [ 96 ].”
Tomura, N., Senoo, K., Okawa, T., Kakei, Y., Kawai, K., Makino, M., Munakata, J., Miki, T., Kato, Y., Fukui, K., et al. (2026) · Journal of Arrhythmia · doi:10.1002/joa3.70477
Doldi, F., Pavel, F., Kreimer, F., Wolfes, J., Ackmann, J., Frommeyer, G., Lüker, J., Güner, F., Köbe, J., Steven, D., et al. (2026) · Heart Rhythm · doi:10.1016/j.hrthm.2026.09.028
Metadata
- Authors
- Vermond, R. A., Geelhoed, B., Verweij, N., Tieleman, R. G., Van der Harst, P., Hillege, H. L., Van Gilst, W. H., Van Gelder, I. C., & Rienstra, M.
- Affiliations
- University Medical Center Groningen (NL)
- Martini Ziekenhuis (NL)
- Corresponding author
- Rienstra, Michiel
- Venue
- Journal of the American College of Cardiology
- Publisher
- Elsevier BV
- Published
- 2015-09
- Volume
- 66
- Issue
- 9
- Pages
- 1000-1007
- ISSN
- 0735-1097 (ISSN-L)
- OpenAlex
- W1951132801
- Cited by
- 297
- References
- 35
- Citations by year
- 2026: 17 · 2025: 27 · 2024: 38 · 2023: 37 · 2022: 29 · 2021: 24 · 2020: 23 · 2019: 22 · 2018: 21 · 2017: 25 · 2016: 31 · 2015: 3
- FWCI
- 19.37
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Journal of the American College of Cardiology (publishedVersion)
- PubMed (publishedVersion)
- University of Groningen research database (University of Groningen / Centre for Information Technology) (publishedVersion, other-oa)
- University of Groningen research database (University of Groningen / Centre for Information Technology) (submittedVersion, other-oa)
- Funders
- Bayer
- Nederlandse Organisatie voor Wetenschappelijk Onderzoek (016.136.055)
- Medtronic
- Bristol-Myers Squibb
- St. Jude Medical
- Boehringer Ingelheim
- Hartstichting (NHS2010B280)
- Pfizer
- Nierstichting (E0.13)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Atrial Fibrillation Management and Outcomes
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac electrophysiology and arrhythmias
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Health and Mental Health
- Keywords
- atrial fibrillation, incidence, cardiovascular events, heart failure, all-cause mortality, obesity, body mass index, risk factors, antihypertensive drugs, hypertension, myocardial infarction, stroke, PREVEND study, older adults
- MeSH terms
- Adult, Aged, Atrial Fibrillation, Cause of Death, Cross-Sectional Studies, Female, Heart Failure, Humans, Male, Middle Aged, Myocardial Infarction, Netherlands, Retrospective Studies, Cohort Studies, Comorbidity, Incidence, Proportional Hazards Models, Survival Analysis, Age Distribution, Sex Distribution, Risk Assessment, Kaplan-Meier Estimate
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review